Mallinckrodt Details Timeline And Financing For Spinning Off Generics Business

 
• By Dean Rudge

Under plans announced last December, Mallinckrodt is to spin off its specialty generics and API business; at the recent Annual J.P. Morgan Healthcare Conference, management painted a timeline to completing the project and provided details on the business’ financing and growth prospects.

Watch
Mallinckrodt has a detailed timeline to completing the planned spin-off • Source: Shutterstock

More from Strategy

More from Business